MC
Muthu Chellappan Deivasigamani
About Muthu Chellappan Deivasigamani
Data last updated:
Muthu Chellappan Deivasigamani is a Director at Biofloris Pharmaceuticals Private Limited (since 2017) and Partner at Kongu Association Llp (since 2015). The companies operate in Pharma and Real Estate and Construction. The largest current company by reported revenue is Biofloris Pharmaceuticals Private Limited at ₹5.84 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2017 | 2017 | ₹5.84 Cr (FY 2025) | Active | |
| Partner | 13 Nov 2015 | 2012 | Active |
Board colleagues of Muthu Chellappan Deivasigamani
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muthu Chellappan Deivasigamani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muthu Chellappan Deivasigamani
Muthu Chellappan Deivasigamani currently holds 2 directorships: Biofloris Pharmaceuticals Private Limited (Director, since 01 Dec 2017, revenue ₹5.84 Cr (FY 2025)); Kongu Association Llp (Partner, since 13 Nov 2015).
Muthu Chellappan Deivasigamani was first appointed on 13 Nov 2015 as Partner at Kongu Association Llp. The most recent appointment on record is 01 Dec 2017 at Biofloris Pharmaceuticals Private Limited.
The current boards of Muthu Chellappan Deivasigamani's companies include Arjunan Karthikeyan (Biofloris Pharmaceuticals Private Limited), Balakrishnan Rajaganesan (Biofloris Pharmaceuticals Private Limited), Dhanasekaran Ravishankar (Biofloris Pharmaceuticals Private Limited), Manickam Rajendran (Biofloris Pharmaceuticals Private Limited), Murugesan Chandrasekaran (Biofloris Pharmaceuticals Private Limited), Premkumar Asokumar (Biofloris Pharmaceuticals Private Limited), among others.